{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:44:58Z","timestamp":1756464298577,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\ufffdHunan Province","doi-asserted-by":"publisher","award":["2021JJ40832"],"award-info":[{"award-number":["2021JJ40832"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Streptococcal toxic shock syndrome (STSS) caused by group A streptococcus is a rare condition that rapidly developed to multiple organ failure even death. Therefore, prompt diagnosis, initiate appropriate antibiotics and other supportive treatments are critical. Here we reported a case of STSS caused by group A streptococcus infection. A healthy 39-year-old man presented a sudden pain in the left lower extremity, followed by a high fever (40.0 \u00b0C) with dizziness, nausea, and shortness of breath. Twenty-four hours before the visit, the patient showed anuria. The patient was then admitted to the intensive care unit. Blood examination revealed elevated levels of inflammatory markers and creatinine. He suffered from septic shock, dysfunction of coagulation, acute kidney dysfunction, acute respiratory distress syndrome, and acute liver function injury. The diagnosis was obtained through clinical manifestation and metagenomic next-generation sequencing (mNGS) drawn from the pustule and deep soft tissue (lower limb) samples while all bacterial cultures came back negative. The pustule mNGS report detected a total of 132 unique group A streptococcus sequence reads, representing 96.3% of microbial reads while the soft tissue mNGS report identified a total of 142474 unique group A streptococcus sequence reads, representing 100% of microbial reads. The patient was treated with aggressive fluid resuscitation, antibiotics comprising piperacillin\/tazobactam and clindamycin, respiratory support, following the delayed surgical debridement. Intravenous immunoglobulin was also used for 5 days. On the 14th day after admission, he was transferred to the general ward for follow-up treatment. Our case highlighted, for the first time, the key role of mNGS in the early diagnosis of culture-negative invasive group A streptococcal infection. The case also suggested that clindamycin combined with beta-lactam antibiotics and adjunction of intravenous immunoglobulin therapy with delayed debridement performed well in the management of unstable STSS patients.<\/jats:p>","DOI":"10.3389\/fpubh.2022.899077","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T10:11:18Z","timestamp":1652263878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Therapeutic Strategy With Delayed Debridement for Culture-Negative Invasive Group A Streptococcal Infections Diagnosed by Metagenomic Next-Generation Sequencing"],"prefix":"10.3389","volume":"10","author":[{"given":"Wenfang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A Streptococcal infections in the United States, 2005-2012","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit Care Med."},{"key":"B3","unstructured":"2010"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a Streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs."},{"key":"B5","first-page":"333","article-title":"Prospective surveillance for invasive Staphylococcus aureus and group A Streptococcus infections in a setting with high community burden of scabies and impetigo","volume-title":"Int J Infect Dis.","author":"Thean","year":"2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3201\/eid15\/2.080558","article-title":"Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007","volume":"15","author":"Steer","year":"2009","journal-title":"Emerg Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ofid\/ofy177","article-title":"Increasing Rates of Invasive Group A Streptococcal Disease in Alberta, Canada; 2003-2017","volume":"5","author":"Tyrrell","year":"2018","journal-title":"Open Forum Infects Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jinf.2014.09.001","article-title":"Increasing incidence of invasive group A streptococcus disease in New Zealand, 2002-2012: a national population-based study","volume":"70","author":"Williamson","year":"2015","journal-title":"J Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/cid\/cir726","article-title":"Invasive bacterial infections in relation to influenza outbreaks, 2006-2010","volume":"53","author":"Tasher","year":"2011","journal-title":"Clin Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.molmed.2013.10.004","article-title":"Streptococcal superantigens: categorization and clinical associations","volume":"20","author":"Commons","year":"2014","journal-title":"Trends Mol Med."},{"key":"B13","first-page":"329","article-title":"Pathogenesis of group A Streptococcal infections","volume":"13","author":"Henningham","year":"2012","journal-title":"Discov Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jinf.2018.05.010","article-title":"Epidemiology of an upsurge of invasive group A Streptococcal infections in Ireland, 2012\u20132015","volume":"77","author":"Meehan","year":"2018","journal-title":"J Infect."},{"key":"B15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.anpede.2019.10.006","article-title":"Invasive Streptococcus pyogenes infections (2011\u20132018): EMM-type and clinical presentation","volume":"92","author":"Mar\u00eda Jos\u00e9","year":"2020","journal-title":"Anales de pediatria."},{"key":"B16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1099\/mic.0.000612","article-title":"The DNases of pathogenic Lancefield streptococci","volume":"164","author":"Remmington","year":"2018","journal-title":"Microbiology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/QCO.0000000000000452","article-title":"Group A Streptococcus infections in children: from virulence to clinical management","volume":"31","author":"Botteaux","year":"2018","journal-title":"Curr Opin Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A Streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","article-title":"Necrotising fasciitis due to group A Streptococci in western Norway: incidence and clinical features","volume":"344","author":"Chelsom","year":"1994","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.amjmed.2020.02.050","article-title":"Multisystemic involvement: Streptococcal toxic shock syndrome","volume":"133","author":"Fernandez-Nieto","year":"2020","journal-title":"Am J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.269.3.390","article-title":"Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","year":"1993","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jemermed.2017.12.048","article-title":"the evaluation and management of toxic shock syndrome in the emergency department: a review of the literature","volume":"54","author":"Gottlieb","year":"2018","journal-title":"J Emerg Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/INF.0000000000002293","article-title":"Highly sensitive molecular assay for group A Streptococci over-identifies carriers and may impact outpatient antimicrobial stewardship","volume":"38","author":"Tanz","year":"2019","journal-title":"Pediatr Infect Dis J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e87882","DOI":"10.1172\/jci.insight.87882","article-title":"Biofilm in group A streptococcal necrotizing soft tissue infections","volume":"1","author":"Siemens","year":"2016","journal-title":"JCI Insight."},{"key":"B27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1371\/journal.pmed.0030053","article-title":"Viable group A streptococci in macrophages during acute soft tissue infection","volume":"3","author":"Thulin","year":"2006","journal-title":"PLoS Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1001\/jama.2018.21669","article-title":"Next-Generation Sequencing of Infectious Pathogens","volume":"321","author":"Gwinn","year":"2019","journal-title":"JAMA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13256-018-1780-2","article-title":"Successful treatment of out-of-hospital cardiopulmonary arrest due to streptococcal toxic shock syndrome - effectiveness of extracorporeal membrane oxygenation and the rapid antigen group A streptococcus test: a case report","volume":"12","author":"Mizuguchi","year":"2018","journal-title":"J Med Case Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease","volume":"11","author":"Saresella","year":"2016","journal-title":"Mol Neurodegener."},{"key":"B31","first-page":"438","article-title":"Antibiotic susceptibilities, streptococcal pyrogenic exotoxin gene profiles among clinical isolates of group C or G Streptococcus dysgalactiae subsp. equisimilis & of group G S anginosus group at a tertiary care centre","volume":"139","author":"Behera","year":"2014","journal-title":"Indian J Med Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"097","DOI":"10.1093\/ofid\/ofz097","article-title":"Potential for molecular testing for group A Streptococcus to improve diagnosis and management in a high-risk population: a prospective study","volume":"6","author":"Ralph","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x mutation confers reduced susceptibility to beta-lactam antibiotics","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci","volume":"18","author":"Mascini","year":"2001","journal-title":"Int J Antimicrob Agents."},{"key":"B35","doi-asserted-by":"publisher","first-page":"760255","DOI":"10.3389\/fmicb.2021.760255","article-title":"Antibiotic Treatment, Mechanisms for Failure, and Adjunctive Therapies for Infections by Group A Streptococcus","volume":"12","author":"Johnson","year":"2021","journal-title":"Front Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"697938","DOI":"10.3389\/fped.2021.697938","article-title":"Invasive Group A Streptococcal Infections: Benefit of Clindamycin, Intravenous Immunoglobulins and Secondary Prophylaxis","volume":"9","author":"Laho","year":"2021","journal-title":"Front pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2106\/JBJS.19.00591","article-title":"Necrotizing fasciitis: pillaging the acute phase response","volume":"102","author":"Hysong","year":"2020","journal-title":"J Bone Joint Surgery Am."},{"key":"B39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/00365540410020866","article-title":"Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach","volume":"37","author":"Norrby-Teglund","year":"2005","journal-title":"Scand J Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study","volume":"59","author":"Linner","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1067\/mai.2001.117820","article-title":"Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses","volume":"108","author":"Schlievert","year":"2001","journal-title":"J Allergy Clin Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/cid\/ciw871","article-title":"Impact of intravenous immunoglobulin on survival in necrotizing fasciitis with vasopressor- dependent shock: a propensity score-matched analysis from 130 US hospitals","volume":"64","author":"Kadri","year":"2017","journal-title":"Clin Infect Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial","volume":"43","author":"Madsen","year":"2017","journal-title":"Intensive Care Med."},{"key":"B46","first-page":"S87","article-title":"[Management of severe invasive group A streptococcal infections]","volume-title":"Arch Pediatr.","author":"Faye","year":"2014"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific intravenous immunoglobulin in Clindamycin-treated patients with Streptococcal toxic shock syndrome: a systematic review and meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/cid\/ciaa022","article-title":"Correlation between immunoglobulin dose administered and plasma neutralization of Streptococcal Superantigens in patients with necrotizing soft tissue infections","volume":"71","author":"Bergsten","year":"2020","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.899077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T10:11:59Z","timestamp":1652263919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.899077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":48,"alternative-id":["10.3389\/fpubh.2022.899077"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.899077","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"article-number":"899077"}}